Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Solriamfetol Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,107Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axsome to narrow focus of depression drug trial after limited success
    Axsome to narrow focus of depression drug trial after limited success

    02 Apr 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/axsomes-depression-treatment-fails-meet-main-goal-late-stage-study-2025-04-01/

    REUTERS
    02 Apr 2025
    Share Share
    Axsome's Sunosi scores in phase 3 ADHD trial
    Axsome's Sunosi scores in phase 3 ADHD trial

    26 Mar 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/axsome-touts-success-phase-3-trial-sunosi-adhd

    FIERCE PHARMA
    26 Mar 2025
    Share Share
    Axsome Therapeutics Settles Sunosi Patent Litigation with Hikma
    Axsome Therapeutics Settles Sunosi Patent Litigation with Hikma

    05 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/05/3037271/33090/en/Axsome-Therapeutics-Settles-Sunosi-solriamfetol-Patent-Litigation-with-Hikma-Pharmaceuticals-USA.html

    GLOBENEWSWIRE
    05 Mar 2025
    Share Share
    Axsome Presents Data from Multiple Programs at Sleep Europe 2024
    Axsome Presents Data from Multiple Programs at Sleep Europe 2024

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2952012/33090/en/Axsome-Therapeutics-Presents-Data-from-Multiple-Programs-at-Sleep-Europe-2024.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share
    Axsome Settles Sunosi Patent Litigation With Sandoz
    Axsome Settles Sunosi Patent Litigation With Sandoz

    21 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/21/2933398/33090/en/Axsome-Therapeutics-Reaches-Agreement-to-Dismiss-Sunosi-Solriamfetol-Patent-Litigation-with-Sandoz-Inc.html

    GLOBENEWSWIRE
    21 Aug 2024
    Share Share
    Axsome Initiates Ph 3 Trial of Solriamfetol for Binge Eating Disorder
    Axsome Initiates Ph 3 Trial of Solriamfetol for Binge Eating Disorder

    01 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/01/2855085/33090/en/Axsome-Therapeutics-Initiates-ENGAGE-Phase-3-Trial-of-Solriamfetol-for-the-Treatment-of-Binge-Eating-Disorder.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share